Abstract
The amount of iron in the plasma is determined by the regulated release of iron from most body cells, but macrophages, intestinal enterocytes and hepatocytes play a particularly important role in this process. This cellular iron efflux is modulated by the liver-derived peptide hepcidin, and this peptide is now regarded as the central regulator of body iron homeostasis. Hepcidin expression is influenced by systemic stimuli such as iron stores, the rate of erythropoiesis, inflammation, hypoxia and oxidative stress. These stimuli control hepcidin levels by acting through hepatocyte cell surface proteins including HFE, transferrin receptor 2, hemojuvelin, TMPRSS6 and the IL-6R. The surface proteins activate various cell signal transduction pathways, including the BMP-SMAD, JAK-STAT and HIF1 pathways, to alter transcription of HAMP, the gene which encodes hepcidin. It is becoming increasingly apparent that various stimuli can signal through multiple pathways to regulate hepcidin expression, and the interplay between positive and negative stimuli is critical in determining the net hepcidin level. The BMP-SMAD pathway appears to be particularly important and disruption of this pathway will abrogate the response of hepcidin to many stimuli.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adamsky K, Weizer O, Amariglio N et al (2004) Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 124:123–124. doi:10.1046/j.1365-2141.2003.04734.x
Ahmad KA, Ahmann JR, Migas MC et al (2002) Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis 29:361–366. doi:10.1006/bcmd.2002.0575
Ameln H, Gustafsson T, Sundberg CJ et al (2005) Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J 19:1009–1011
Babitt JL, Huang FW, Xia Y et al (2007) Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 117:1933–1939. doi:10.1172/JCI31342
Babitt JL, Huang FW, Wrighting DM et al (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38:531–539. doi:10.1038/ng1777
Bekri S, Gual P, Anty R et al (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131:788–796. doi:10.1053/j.gastro.2006.07.007
Bennett MJ, Lebron JA, Bjorkman PJ (2000) Crystal structure of the hereditary hemochromatosis protein HFE complexed with transferrin receptor. Nature 403:46–53. doi:10.1038/47417
Bralet MP, Duclos-Vallee JC, Castaing D et al (2004) No hepatic iron overload 12 years after liver transplantation for hereditary hemochromatosis. Hepatology 40:762. doi:10.1002/hep.20398 author reply 762
Bridle KR, Frazer DM, Wilkins SJ et al (2003) Disrupted hepcidin regulation in HFE-associated hemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361:669–673. doi:10.1016/S0140-6736(03)12602-5
Brittenham GM (1994) The red cell cycle. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. WB Suanders Company Ltd, London, pp 31–62
Calzolari A, Raggi C, Deaglio S et al (2006) TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J Cell Sci 119:4486–4498. doi:10.1242/jcs.03228
Camaschella C, Roetto A, Cali A et al (2000) The gene TFR2 is mutated in a new type of hemochromatosis mapping to 7q22. Nat Genet 25:14–15. doi:10.1038/75534
Chaston T, Chung B, Mascarenhas M et al (2008) Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut 57:374–382. doi:10.1136/gut.2007.131722
De Domenico I, Ward DM, Langelier C et al (2007) The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18:2569–2578. doi:10.1091/mbc.E07-01-0060
Drakesmith H, Schimanski LM, Ormerod E et al (2005) Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106:1092–1097. doi:10.1182/blood-2005-02-0561
Du X, She E, Gelbart T et al (2008) The serine protease TMPRSS6 is required to sense iron deficiency. Science 320:1088–1092. doi:10.1126/science.1157121
Feder JN, Penny DM, Irrinki A et al (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95:1472–1477. doi:10.1073/pnas.95.4.1472
Feder JN, Gnirke A, Thomas W et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 13:399–408. doi:10.1038/ng0896-399
Finberg KE, Heeney MM, Campagna DR et al (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40:569–571. doi:10.1038/ng.130
Folgueras AR, de Lara FM, Pendas AM et al (2008) Membrane-bound serine protease matriptase–2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112:2539–2545. doi:10.1182/blood-2008-04-149773
Frazer DM, Anderson GJ (2003) The orchestration of body iron intake: how and where do enterocytes receive their cues? Blood Cells Mol Dis 30:288–297. doi:10.1016/S1079-9796(03)00039-1
Frazer DM, Wilkins SJ, Millard KN et al (2004a) Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFE. Br J Haematol 126:434–436. doi:10.1111/j.1365-2141.2004.05044.x
Frazer DM, Wilkins SJ, Becker EM et al (2002) Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 123:835–844. doi:10.1053/gast.2002.35353
Frazer DM, Inglis HR, Wilkins SJ et al (2004b) Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 53:1509–1515. doi:10.1136/gut.2003.037416
Gardenghi S, Marongiu MF, Ramos P et al (2007) Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109:5027–5035. doi:10.1182/blood-2006-09-048868
Gehrke SG, Herrmann T, Kulaksiz H et al (2005) Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway. Digestion 72:25–32. doi:10.1159/000087400
Goswami T, Andrews NC (2006) Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 281:28494–28498. doi:10.1074/jbc.C600197200
Guillem F, Lawson S, Kannengiesser C et al (2008) Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 112:2089–2091. doi:10.1182/blood-2008-05-154740
Huang FW, Pinkus JL, Pinkus GS et al (2005) A mouse model of juvenile hemochromatosis. J Clin Invest 115:2187–2191. doi:10.1172/JCI25049
Huebers HA, Finch CA (1987) The physiology of transferrin and transferrin receptors. Physiol Rev 67:520–582
Johnson MB, Enns CA (2004) Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104:4287–4293. doi:10.1182/blood-2004-06-2477
Kanda J, Mizumoto C, Kawabata H et al (2008) Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica 93:1550–1554. doi:10.3324/haematol.12399
Kemna E, Pickkers P, Nemeth E et al (2005) Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106:1864–1866. doi:10.1182/blood-2005-03-1159
Krause A, Neitz S, Magert HJ et al (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480:147–150. doi:10.1016/S0014-5793(00)01920-7
Kuninger D, Kuns-Hashimoto R, Kuzmickas R et al (2006) Complex biosynthesis of the muscle-enriched iron regulator RGMc. J Cell Sci 119:3273–3283. doi:10.1242/jcs.03074
Laftah AH, Ramesh B, Simpson RJ et al (2004) Effect of hepcidin on intestinal iron absorption in mice. Blood 103:3940–3944. doi:10.1182/blood-2003-03-0953
Lebron JA, Bennett MJ, Vaughn DE et al (1998) Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93:111–123. doi:10.1016/S0092-8674(00)81151-4
Lee P, Peng H, Gelbart T et al (2004) The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci USA 101:9263–9265. doi:10.1073/pnas.0403108101
Lee P, Peng H, Gelbart T et al (2005) Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 102:1906–1910. doi:10.1073/pnas.0409808102
Lim JE, Jin O, Bennett C et al (2005) A mutation in Sec15l1 causes anemia in hemoglobin deficit (hbd) mice. Nat Genet 37:1270–1273. doi:10.1038/ng1659
Lin L, Goldberg YP, Ganz T (2005) Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106:2884–2889. doi:10.1182/blood-2005-05-1845
Lin L, Nemeth E, Goodnough JB et al (2008) Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol Dis 40:122–131. doi:10.1016/j.bcmd.2007.06.023
Lundby C, Gassmann M, Pilegaard H (2006) Regular endurance training reduces the exercise induced HIF-1alpha and HIF-2alpha mRNA expression in human skeletal muscle in normoxic conditions. Eur J Appl Physiol 96:363–369. doi:10.1007/s00421-005-0085-5
McMahon S, Grondin F, McDonald PP et al (2005) Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins. J Biol Chem 280:6561–6569. doi:10.1074/jbc.M413248200
Melis MA, Cau M, Congui R et al (2008) A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that supresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 93:1473–1479. doi:10.3324/haematol.13342
Nemeth E, Roetto A, Garozzo G et al (2005) Hepcidin is decreased in TFR2 hemochromatosis. Blood 105:1803–1806. doi:10.1182/blood-2004-08-3042
Nemeth E, Rivera S, Gabayan V et al (2004a) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271–1276
Nemeth E, Tuttle MS, Powelson J et al (2004b) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–2093. doi:10.1126/science.1104742
Nicolas G, Bennoun M, Devaux I et al (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98:8780–8785. doi:10.1073/pnas.151179498
Nicolas G, Viatte L, Lou DQ et al (2003) Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 34:97–101. doi:10.1038/ng1150
Nicolas G, Chauvet C, Viatte L et al (2002a) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110:1037–1044
Nicolas G, Bennoun M, Porteu A et al (2002b) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99:4596–4601. doi:10.1073/pnas.072632499
Pak M, Lopez MA, Gabayan V et al (2006) Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108:3730–3735. doi:10.1182/blood-2006-06-028787
Papanikolaou G, Tzilianos M, Christakis JI et al (2005) Hepcidin in iron overload disorders. Blood 105:4103–4105. doi:10.1182/blood-2004-12-4844
Papanikolaou G, Samuels ME, Ludwig EH et al (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77–82. doi:10.1038/ng1274
Park CH, Valore EV, Waring AJ et al (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806–7810. doi:10.1074/jbc.M008922200
Parkkila S, Waheed A, Britton RS et al (1997) Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 94:13198–13202. doi:10.1073/pnas.94.24.13198
Peyssonnaux C, Zinkernagel AS, Schuepbach RA et al (2007) Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 117:1926–1932. doi:10.1172/JCI31370
Pigeon C, Ilyin G, Courselaud B et al (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811–7819. doi:10.1074/jbc.M008923200
Rivera S, Liu L, Nemeth E et al (2005a) Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood 105:1797–1802. doi:10.1182/blood-2004-08-3375
Rivera S, Nemeth E, Gabayan V et al (2005b) Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106:2196–2199. doi:10.1182/blood-2005-04-1766
Robb A, Wessling-Resnick M (2004) Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104:4294–4299. doi:10.1182/blood-2004-06-2481
Roetto A, Papanikolaou G, Politou M et al (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22. doi:10.1038/ng1053
Roetto A, Totaro A, Cazzola M et al (1999) Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet 64:1388–1393. doi:10.1086/302379
Schmidt PJ, Toran PT, Giannetti AM et al (2008) The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab 7:205–214. doi:10.1016/j.cmet.2007.11.016
Silvestri L, Pagani A, Camaschella C (2008) Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 111:924–931. doi:10.1182/blood-2007-07-100677
Tanno T, Bhanu NV, Oneal PA et al (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13:1096–1101. doi:10.1038/nm1629
Truksa J, Peng H, Lee P et al (2006) Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci USA 103:10289–10293. doi:10.1073/pnas.0603124103
Verga Falzacappa MV, Casanovas G, Hentze MW et al (2008) A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells. J Mol Med 86:531–540. doi:10.1007/s00109-008-0313-7
Verga Falzacappa MV, Vujic Spasic M, Kessler R et al (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109:353–358. doi:10.1182/blood-2006-07-033969
Vokurka M, Krijt J, Sulc K et al (2006) Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 55:667–674
Vujic Spasic M, Kiss J, Herrmann T et al (2008) Hfe acts in hepatocytes to prevent hemochromatosis. Cell Metab 7:173–178. doi:10.1016/j.cmet.2007.11.014
Vujic Spasic M, Kiss J, Herrmann T et al (2007) Physiologic systemic iron metabolism in mice deficient for duodenal Hfe. Blood 109:4511–4517. doi:10.1182/blood-2006-07-036186
Wang RH, Li C, Xu X et al (2005) A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2:399–409. doi:10.1016/j.cmet.2005.10.010
Wilkins SJ, Frazer DM, Millard KN et al (2006) Iron metabolism in the hemoglobin-deficit mouse: correlation of diferric transferrin with hepcidin expression. Blood 107:1659–1664. doi:10.1182/blood-2005-07-2614
Wrighting DM, Andrews NC (2006) Interleukin–6 induces hepcidin expression through STAT3. Blood 108:3204–3209. doi:10.1182/blood-2006-06-027631
Xia Y, Babitt JL, Sidis Y et al (2008) Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 111:5195–5204. doi:10.1182/blood-2007-09-111567
Yu PB, Hong CC, Sachidanandan C et al (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4:33–41. doi:10.1038/nchembio.2007.54
Zhang AS, Sheftel AD, Ponka P (2006) The anemia of “hemoglobin-deficit” (hbd/hbd) mice is caused by a defect in transferrin cycling. Exp Hematol 34:593–598. doi:10.1016/j.exphem.2006.02.004
Zhang AS, West AP Jr, Wyman AE et al (2005) Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. J Biol Chem 280:33885–33894. doi:10.1074/jbc.M506207200
Zhang AS, Anderson SA, Meyers KR et al (2007) Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J Biol Chem 282:12547–12556. doi:10.1074/jbc.M608788200
Acknowledgements
GJA is supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Darshan, D., Anderson, G.J. Interacting signals in the control of hepcidin expression. Biometals 22, 77–87 (2009). https://doi.org/10.1007/s10534-008-9187-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-008-9187-y